Navigation Links
Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
Date:3/18/2009

rmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus. For further information about Idenix, please refer to www.idenix.com.

Forward-looking Statements

This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward- looking statements can be identified by the use of forward-looking terminology such as "expect," "may," "plans," "anticipates," "preliminary," "will," or similar expressions, or by express or implied statements with respect to the company's clinical development programs or commercialization activities in hepatitis C, or any potential pipeline candidates and expectations with respect to future milestone payments and cash balances at the end of 2009 or beyond. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by unexpected regulatory actions or delays; uncertainties relating to, or unsuccessful results of, clinical trials, including additional data relating to the ongoing clinical trials evaluating its product candidates; the company's ability to obtain additional funding required to conduct its research, development and commercialization activities; the company's dependence on third party collaborators, changes in the company's business plan or objectives; the ability of the company to attract and retain qualified personnel; competition in general; and the company's ability to obtain, maintain a
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
9. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
10. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
11. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 6, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... fourth quarter of 2014 on March 26, 2015 after ... Bioscience will also host a conference call at 4:30 ... it,s fourth quarter financial results. During the conference call, ...
(Date:3/6/2015)... -- Health eCareers, the only online single-source healthcare recruiting ... announced the launch of ENA Job Center , ... ENA Job Center provides a powerful venue for the ... openings and for employers to reach the widest possible ... field. Job seekers now have a ...
(Date:3/6/2015)... Raleigh, NC (PRWEB) March 06, 2015 ... has formally announced its new name, Able&Co. , The ... has experienced impressive growth since its inception, continuing to ... a seasoned and multi-disciplined agency with a core focus ... the future, we want our name and visual identity ...
(Date:3/6/2015)... --  InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the ... it will release its full financial results for the fourth ... 12 th after market close, followed by a conference ... and business outlook. Participants should call (888) 243-4451 ... and request the InspireMD call. A live webcast of the ...
Breaking Biology Technology:Roka Bioscience to Report Fourth Quarter 2015 Financial Results On March 26, 2015 2Health eCareers Announces Online Career Center for the Emergency Nurses Association 2Health eCareers Announces Online Career Center for the Emergency Nurses Association 3Red House Group Reveals New Identity as Able&Co. 2InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th 2
... March 3 Osteotech, Inc.,(Nasdaq: OSTE ), ... solutions for,regenerative medicine, announced today that Sam Owusu-Akyaw, ... the Canaccord Adams,Small-Cap Orthopedics Conference at the Mission ... Owusu-Akyaw is scheduled to present at 3:10 p.m.,Pacific ...
... 3 For the second month in a row,the capital ... the last day of the month the Dow dropped over ... the first time. Amid these,fears, biotech was dragged down with ... down 5% and the Dow, which closed down,3%., "The ...
... Trent 1000 engines have been selected, - New environmental partnership with ... ... burn, SOUTH NORWALK, Conn., March 3 ... selected,Rolls-Royce Trent 1000 engines to power its Boeing 787-9 fleet of aircraft., ...
Cached Biology Technology:Biotech Drops Amid Tough Markets in February 2Biotech Drops Amid Tough Markets in February 3Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 2Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 3Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 4
(Date:3/5/2015)... In Brazil , cloud computing is fast ... and 42 percent planning to invest in them by the ... the companies will be investing in these solutions for the ... the region are currently opting for the private cloud model, ... attention in the coming years. This trend is in line ...
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Global Biometrics Market Forecast and ... The market for biometric authentication systems is ... 14% till 2020 The driving forces ... security needs, government projects and constant development in ...
(Date:3/3/2015)... FOREST, Calif. , March 3, 2015 ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, today announced the expansion ... Cancer Research Centers, ("Fred Hutch") Clinical ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... the International Society for Stem Cell Research (ISSCR), the ... new guidelines for the responsible development of safe and ... that summarizes the Guidelines for the Clinical Translation of ... the December issue of Cell Stem Cell , ...
... - other asthma drugs have not been as well studied ... same asthma drugs they were using before they got pregnant. ... as safe. More trials of other essential medicines are necessary ... in Health Care (IQWiG), more data from trials could reassure ...
... come with some substantial benefits for some women, according to ... Anthropology . The hormones that make women physically ... also tend to redistribute fat from the hips to the ... of Utah. So in societies and situations where women are ...
Cached Biology News:The International Society for Stem Cell Research releases new guidelines 2The International Society for Stem Cell Research releases new guidelines 3Pregnant women with asthma can be more confident about some medicines 2Why the 'perfect' body isn't always perfect 2
Custom LNA Oligonucleotide synthesis ,High quality Custom LNA Oligonucleotides are available for a variety of different specialty applications and innovative products. ,Please inquire for further...
... 'Agilents GeneSpring Workgroup solution is a ... and mining expression data in a ... is deployed in over 40 leading ... organizations worldwide. GeneSpring Workgroup streamlines genomics ...
... blotting is a commonly used technique for ... samples are electrophoresed on SDS-PAGE and transferred ... nylon, where they are probed with specific ... allow reuse of Southern and Northern blots, ...
... peptide microarrays designed for quantitative assays ... and built on the flexible and ... of customer specified sequences can be ... provide assistance with custom sequence design. ...
Biology Products: